CVS Health struck a deal with dissident Glenview Capital, giving the investor four board seats. Glenview had been pushing for changes at the health-care giant and had met with former CEO Karen Lynch prior to her ouster.

CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its brutal 2024.

(Reuters) -CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins. Shares of the healthcare conglomerate rose nearly 3% in premarket trading.